Global MSD Drugs Market Growth 2020-2025
According to this study, over the next five years the MSD Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in MSD Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of MSD Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the MSD Drugs, covering the supply chain analysis, impact assessment to the MSD Drugs market size growth rate in several scenarios, and the measures to be undertaken by MSD Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
OTC
Rx Drugs
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Retail Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AbbVie
Amgen
Roche
Pfizer Inc
Johnson & Johnson
Eli Lilly
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global MSD Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of MSD Drugs market by identifying its various subsegments.
Focuses on the key global MSD Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the MSD Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of MSD Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global MSD Drugs Consumption 2015-2025
2.1.2 MSD Drugs Consumption CAGR by Region
2.2 MSD Drugs Segment by Type
2.2.1 OTC
2.2.2 Rx Drugs
2.3 MSD Drugs Consumption by Type
2.3.1 Global MSD Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global MSD Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global MSD Drugs Sale Price by Type (2015-2020)
2.4 MSD Drugs Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.5 MSD Drugs Consumption by Application
2.5.1 Global MSD Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global MSD Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global MSD Drugs Sale Price by Type (2015-2020)
3 Global MSD Drugs by Company
3.1 Global MSD Drugs Sales Market Share by Company
3.1.1 Global MSD Drugs Sales by Company (2018-2020)
3.1.2 Global MSD Drugs Sales Market Share by Company (2018-2020)
3.2 Global MSD Drugs Revenue Market Share by Company
3.2.1 Global MSD Drugs Revenue by Company (2018-2020)
3.2.2 Global MSD Drugs Revenue Market Share by Company (2018-2020)
3.3 Global MSD Drugs Sale Price by Company
3.4 Global MSD Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global MSD Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players MSD Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 MSD Drugs by Regions
4.1 MSD Drugs by Regions
4.2 Americas MSD Drugs Consumption Growth
4.3 APAC MSD Drugs Consumption Growth
4.4 Europe MSD Drugs Consumption Growth
4.5 Middle East & Africa MSD Drugs Consumption Growth
5 Americas
5.1 Americas MSD Drugs Consumption by Countries
5.1.1 Americas MSD Drugs Consumption by Countries (2015-2020)
5.1.2 Americas MSD Drugs Value by Countries (2015-2020)
5.2 Americas MSD Drugs Consumption by Type
5.3 Americas MSD Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC MSD Drugs Consumption by Regions
6.1.1 APAC MSD Drugs Consumption by Regions (2015-2020)
6.1.2 APAC MSD Drugs Value by Regions (2015-2020)
6.2 APAC MSD Drugs Consumption by Type
6.3 APAC MSD Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe MSD Drugs by Countries
7.1.1 Europe MSD Drugs Consumption by Countries (2015-2020)
7.1.2 Europe MSD Drugs Value by Countries (2015-2020)
7.2 Europe MSD Drugs Consumption by Type
7.3 Europe MSD Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa MSD Drugs by Countries
8.1.1 Middle East & Africa MSD Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa MSD Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa MSD Drugs Consumption by Type
8.3 Middle East & Africa MSD Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 MSD Drugs Distributors
10.3 MSD Drugs Customer
11 Global MSD Drugs Market Forecast
11.1 Global MSD Drugs Consumption Forecast (2021-2025)
11.2 Global MSD Drugs Forecast by Regions
11.2.1 Global MSD Drugs Forecast by Regions (2021-2025)
11.2.2 Global MSD Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global MSD Drugs Forecast by Type
11.8 Global MSD Drugs Forecast by Application
12 Key Players Analysis
12.1 AbbVie
12.1.1 Company Information
12.1.2 MSD Drugs Product Offered
12.1.3 AbbVie MSD Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AbbVie Latest Developments
12.2 Amgen
12.2.1 Company Information
12.2.2 MSD Drugs Product Offered
12.2.3 Amgen MSD Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Amgen Latest Developments
12.3 Roche
12.3.1 Company Information
12.3.2 MSD Drugs Product Offered
12.3.3 Roche MSD Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Roche Latest Developments
12.4 Pfizer Inc
12.4.1 Company Information
12.4.2 MSD Drugs Product Offered
12.4.3 Pfizer Inc MSD Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Pfizer Inc Latest Developments
12.5 Johnson & Johnson
12.5.1 Company Information
12.5.2 MSD Drugs Product Offered
12.5.3 Johnson & Johnson MSD Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Johnson & Johnson Latest Developments
12.6 Eli Lilly
12.6.1 Company Information
12.6.2 MSD Drugs Product Offered
12.6.3 Eli Lilly MSD Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Eli Lilly Latest Developments
...
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. MSD Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of OTC
Table 5. Major Players of Rx Drugs
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global MSD Drugs Consumption Market Share by Type (2015-2020)
Table 8. Global MSD Drugs Revenue by Type (2015-2020) ($ million)
Table 9. Global MSD Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global MSD Drugs Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global MSD Drugs Consumption Market Share by Application (2015-2020)
Table 13. Global MSD Drugs Value by Application (2015-2020)
Table 14. Global MSD Drugs Value Market Share by Application (2015-2020)
Table 15. Global MSD Drugs Sale Price by Application (2015-2020)
Table 16. Global MSD Drugs Sales by Company (2017-2019) (K Units)
Table 17. Global MSD Drugs Sales Market Share by Company (2017-2019)
Table 18. Global MSD Drugs Revenue by Company (2017-2019) ($ Millions)
Table 19. Global MSD Drugs Revenue Market Share by Company (2017-2019)
Table 20. Global MSD Drugs Sale Price by Company (2017-2019)
Table 21. Global MSD Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players MSD Drugs Products Offered
Table 23. MSD Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global MSD Drugs Consumption by Regions 2015-2020 (K Units)
Table 25. Global MSD Drugs Consumption Market Share by Regions 2015-2020
Table 26. Global MSD Drugs Value by Regions 2015-2020 ($ Millions)
Table 27. Global MSD Drugs Value Market Share by Regions 2015-2020
Table 28. Americas MSD Drugs Consumption by Countries (2015-2020) (K Units)
Table 29. Americas MSD Drugs Consumption Market Share by Countries (2015-2020)
Table 30. Americas MSD Drugs Value by Countries (2015-2020) ($ Millions)
Table 31. Americas MSD Drugs Value Market Share by Countries (2015-2020)
Table 32. Americas MSD Drugs Consumption by Type (2015-2020) (K Units)
Table 33. Americas MSD Drugs Consumption Market Share by Type (2015-2020)
Table 34. Americas MSD Drugs Consumption by Application (2015-2020) (K Units)
Table 35. Americas MSD Drugs Consumption Market Share by Application (2015-2020)
Table 36. APAC MSD Drugs Consumption by Regions (2015-2020) (K Units)
Table 37. APAC MSD Drugs Consumption Market Share by Regions (2015-2020)
Table 38. APAC MSD Drugs Value by Regions (2015-2020) ($ Millions)
Table 39. APAC MSD Drugs Value Market Share by Regions (2015-2020)
Table 40. APAC MSD Drugs Consumption by Type (2015-2020) (K Units)
Table 41. APAC MSD Drugs Consumption Market Share by Type (2015-2020)
Table 42. APAC MSD Drugs Consumption by Application (2015-2020) (K Units)
Table 43. APAC MSD Drugs Consumption Market Share by Application (2015-2020)
Table 44. Europe MSD Drugs Consumption by Countries (2015-2020) (K Units)
Table 45. Europe MSD Drugs Consumption Market Share by Countries (2015-2020)
Table 46. Europe MSD Drugs Value by Countries (2015-2020) ($ Millions)
Table 47. Europe MSD Drugs Value Market Share by Countries (2015-2020)
Table 48. Europe MSD Drugs Consumption by Type (2015-2020) (K Units)
Table 49. Europe MSD Drugs Consumption Market Share by Type (2015-2020)
Table 50. Europe MSD Drugs Consumption by Application (2015-2020) (K Units)
Table 51. Europe MSD Drugs Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa MSD Drugs Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa MSD Drugs Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa MSD Drugs Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa MSD Drugs Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa MSD Drugs Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa MSD Drugs Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa MSD Drugs Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa MSD Drugs Consumption Market Share by Application (2015-2020)
Table 60. MSD Drugs Distributors List
Table 61. MSD Drugs Customer List
Table 62. Global MSD Drugs Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global MSD Drugs Consumption Market Forecast by Regions
Table 64. Global MSD Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global MSD Drugs Value Market Share Forecast by Regions
Table 66. Global MSD Drugs Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global MSD Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global MSD Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global MSD Drugs Value Market Share Forecast by Type (2021-2025)
Table 70. Global MSD Drugs Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global MSD Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global MSD Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global MSD Drugs Value Market Share Forecast by Application (2021-2025)
Table 74. AbbVie Product Offered
Table 75. AbbVie MSD Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. AbbVie Main Business
Table 77. AbbVie Latest Developments
Table 78. AbbVie Basic Information, Company Total Revenue (in $ million), MSD Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Amgen Product Offered
Table 80. Amgen MSD Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Amgen Main Business
Table 82. Amgen Latest Developments
Table 83. Amgen Basic Information, Company Total Revenue (in $ million), MSD Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Roche Product Offered
Table 85. Roche MSD Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Roche Main Business
Table 87. Roche Latest Developments
Table 88. Roche Basic Information, Company Total Revenue (in $ million), MSD Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Inc Product Offered
Table 90. Pfizer Inc MSD Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Pfizer Inc Main Business
Table 92. Pfizer Inc Latest Developments
Table 93. Pfizer Inc Basic Information, Company Total Revenue (in $ million), MSD Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Product Offered
Table 95. Johnson & Johnson MSD Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), MSD Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Eli Lilly Product Offered
Table 100. Eli Lilly MSD Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Eli Lilly Main Business
Table 102. Eli Lilly Latest Developments
Table 103. Eli Lilly Basic Information, Company Total Revenue (in $ million), MSD Drugs Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of MSD Drugs
Figure 2. MSD Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global MSD Drugs Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global MSD Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of OTC
Figure 7. Product Picture of Rx Drugs
Figure 8. Global MSD Drugs Consumption Market Share by Type (2015-2020)
Figure 9. Global MSD Drugs Value Market Share by Type (2015-2020)
Figure 10. MSD Drugs Consumed in Hospital
Figure 11. Global MSD Drugs Market: Hospital (2015-2020) (K Units)
Figure 12. Global MSD Drugs Market: Hospital (2015-2020) ($ Millions)
Figure 13. MSD Drugs Consumed in Retail Pharmacy
Figure 14. Global MSD Drugs Market: Retail Pharmacy (2015-2020) (K Units)
Figure 15. Global MSD Drugs Market: Retail Pharmacy (2015-2020) ($ Millions)
Figure 16. Global MSD Drugs Consumption Market Share by Application (2015-2020)
Figure 17. Global MSD Drugs Value Market Share by Application (2015-2020)
Figure 18. Global MSD Drugs Sales Market Share by Company in 2017
Figure 19. Global MSD Drugs Sales Market Share by Company in 2019
Figure 20. Global MSD Drugs Revenue Market Share by Company in 2017
Figure 21. Global MSD Drugs Revenue Market Share by Company in 2019
Figure 22. Global MSD Drugs Sale Price by Company in 2019
Figure 23. Global MSD Drugs Consumption Market Share by Regions 2015-2020
Figure 24. Global MSD Drugs Value Market Share by Regions 2015-2020
Figure 25. Americas MSD Drugs Consumption 2015-2020 (K Units)
Figure 26. Americas MSD Drugs Value 2015-2020 ($ Millions)
Figure 27. APAC MSD Drugs Consumption 2015-2020 (K Units)
Figure 28. APAC MSD Drugs Value 2015-2020 ($ Millions)
Figure 29. Europe MSD Drugs Consumption 2015-2020 (K Units)
Figure 30. Europe MSD Drugs Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa MSD Drugs Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa MSD Drugs Value 2015-2020 ($ Millions)
Figure 33. Americas MSD Drugs Consumption Market Share by Countries in 2019
Figure 34. Americas MSD Drugs Value Market Share by Countries in 2019
Figure 35. Americas MSD Drugs Consumption Market Share by Type in 2019
Figure 36. Americas MSD Drugs Consumption Market Share by Application in 2019
Figure 37. United States MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 38. United States MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 39. Canada MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 40. Canada MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 43. APAC MSD Drugs Consumption Market Share by Countries in 2019
Figure 44. APAC MSD Drugs Value Market Share by Regions in 2019
Figure 45. APAC MSD Drugs Consumption Market Share by Type in 2019
Figure 46. APAC MSD Drugs Consumption Market Share by Application in 2019
Figure 47. China MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 48. China MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 49. Japan MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 50. Japan MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 51. Korea MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 52. Korea MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 55. India MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 56. India MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 57. Australia MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 58. Australia MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 59. Europe MSD Drugs Consumption Market Share by Countries in 2019
Figure 60. Europe MSD Drugs Value Market Share by Countries in 2019
Figure 61. Europe MSD Drugs Consumption Market Share by Type in 2019
Figure 62. Europe MSD Drugs Consumption Market Share by Application in 2019
Figure 63. Germany MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 64. Germany MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 65. France MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 66. France MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 67. UK MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 68. UK MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 69. Italy MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 70. Italy MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 71. Russia MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 72. Russia MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa MSD Drugs Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa MSD Drugs Value Market Share by Countries in 2019
Figure 75. Middle East & Africa MSD Drugs Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa MSD Drugs Consumption Market Share by Application in 2019
Figure 77. Egypt MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 81. Israel MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 82. Israel MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries MSD Drugs Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries MSD Drugs Value Growth 2015-2020 ($ Millions)
Figure 87. Global MSD Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global MSD Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas MSD Drugs Consumption 2021-2025 (K Units)
Figure 90. Americas MSD Drugs Value 2021-2025 ($ Millions)
Figure 91. APAC MSD Drugs Consumption 2021-2025 (K Units)
Figure 92. APAC MSD Drugs Value 2021-2025 ($ Millions)
Figure 93. Europe MSD Drugs Consumption 2021-2025 (K Units)
Figure 94. Europe MSD Drugs Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa MSD Drugs Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa MSD Drugs Value 2021-2025 ($ Millions)
Figure 97. United States MSD Drugs Consumption 2021-2025 (K Units)
Figure 98. United States MSD Drugs Value 2021-2025 ($ Millions)
Figure 99. Canada MSD Drugs Consumption 2021-2025 (K Units)
Figure 100. Canada MSD Drugs Value 2021-2025 ($ Millions)
Figure 101. Mexico MSD Drugs Consumption 2021-2025 (K Units)
Figure 102. Mexico MSD Drugs Value 2021-2025 ($ Millions)
Figure 103. Brazil MSD Drugs Consumption 2021-2025 (K Units)
Figure 104. Brazil MSD Drugs Value 2021-2025 ($ Millions)
Figure 105. China MSD Drugs Consumption 2021-2025 (K Units)
Figure 106. China MSD Drugs Value 2021-2025 ($ Millions)
Figure 107. Japan MSD Drugs Consumption 2021-2025 (K Units)
Figure 108. Japan MSD Drugs Value 2021-2025 ($ Millions)
Figure 109. Korea MSD Drugs Consumption 2021-2025 (K Units)
Figure 110. Korea MSD Drugs Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia MSD Drugs Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia MSD Drugs Value 2021-2025 ($ Millions)
Figure 113. India MSD Drugs Consumption 2021-2025 (K Units)
Figure 114. India MSD Drugs Value 2021-2025 ($ Millions)
Figure 115. Australia MSD Drugs Consumption 2021-2025 (K Units)
Figure 116. Australia MSD Drugs Value 2021-2025 ($ Millions)
Figure 117. Germany MSD Drugs Consumption 2021-2025 (K Units)
Figure 118. Germany MSD Drugs Value 2021-2025 ($ Millions)
Figure 119. France MSD Drugs Consumption 2021-2025 (K Units)
Figure 120. France MSD Drugs Value 2021-2025 ($ Millions)
Figure 121. UK MSD Drugs Consumption 2021-2025 (K Units)
Figure 122. UK MSD Drugs Value 2021-2025 ($ Millions)
Figure 123. Italy MSD Drugs Consumption 2021-2025 (K Units)
Figure 124. Italy MSD Drugs Value 2021-2025 ($ Millions)
Figure 125. Russia MSD Drugs Consumption 2021-2025 (K Units)
Figure 126. Russia MSD Drugs Value 2021-2025 ($ Millions)
Figure 127. Spain MSD Drugs Consumption 2021-2025 (K Units)
Figure 128. Spain MSD Drugs Value 2021-2025 ($ Millions)
Figure 129. Egypt MSD Drugs Consumption 2021-2025 (K Units)
Figure 130. Egypt MSD Drugs Value 2021-2025 ($ Millions)
Figure 131. South Africa MSD Drugs Consumption 2021-2025 (K Units)
Figure 132. South Africa MSD Drugs Value 2021-2025 ($ Millions)
Figure 133. Israel MSD Drugs Consumption 2021-2025 (K Units)
Figure 134. Israel MSD Drugs Value 2021-2025 ($ Millions)
Figure 135. Turkey MSD Drugs Consumption 2021-2025 (K Units)
Figure 136. Turkey MSD Drugs Value 2021-2025 ($ Millions)
Figure 137. GCC Countries MSD Drugs Consumption 2021-2025 (K Units)
Figure 138. GCC Countries MSD Drugs Value 2021-2025 ($ Millions)
Figure 139. AbbVie MSD Drugs Market Share (2018-2020)
Figure 140. Amgen MSD Drugs Market Share (2018-2020)
Figure 141. Roche MSD Drugs Market Share (2018-2020)
Figure 142. Pfizer Inc MSD Drugs Market Share (2018-2020)
Figure 143. Johnson & Johnson MSD Drugs Market Share (2018-2020)
Figure 144. Eli Lilly MSD Drugs Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets